Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros Foukakis

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Breast Cancer Research and Treatment|December 1, 2017
Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancerAlexios Matikas, Sara Margolin, Mats Hellström, et al.
Cancer|December 19, 2019
Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer: Results from the phase 3 PANTHER trialAntroula Papakonstantinou, Alexios Matikas, Nils Olof Bengtsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2024
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER TrialAlexios Matikas, Volker Möbus, Richard Greil, et al.
NPJ Breast Cancer|March 7, 2025
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trialIoannis Zerdes, Alexios Matikas, Artur Mezheyeuski, et al.
British Journal of Cancer|January 26, 2018
Immune gene expression and response to chemotherapy in advanced breast cancerTheodoros Foukakis, John Lövrot, Alexios Matikas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer PatientsNicholas P Tobin, Arian Lundberg, Linda S Lindström, et al.
Cancer Cell|November 15, 2017
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor ProgressionAsis Palazon, Petros A Tyrakis, David Macias, et al.
The Lancet Regional Health. Europe|September 22, 2025
Prognostic significance of tumour Ki-67 dynamics during neoadjuvant treatment in patients with breast cancer: a population-based cohort studyMaria Angeliki Toli, Xingrong Liu, Davide Massa, et al.
NPJ Breast Cancer|November 20, 2021
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility studyIoannis Zerdes, Michele Simonetti, Alexios Matikas, et al.
Nature Communications|May 7, 2024
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancerKang Wang, Ioannis Zerdes, Henrik J Johansson, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Breast Cancer Research and Treatment|December 1, 2017
Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancerAlexios Matikas, Sara Margolin, Mats Hellström, et al.
Cancer|December 19, 2019
Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer: Results from the phase 3 PANTHER trialAntroula Papakonstantinou, Alexios Matikas, Nils Olof Bengtsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2024
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER TrialAlexios Matikas, Volker Möbus, Richard Greil, et al.
NPJ Breast Cancer|March 7, 2025
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trialIoannis Zerdes, Alexios Matikas, Artur Mezheyeuski, et al.
British Journal of Cancer|January 26, 2018
Immune gene expression and response to chemotherapy in advanced breast cancerTheodoros Foukakis, John Lövrot, Alexios Matikas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer PatientsNicholas P Tobin, Arian Lundberg, Linda S Lindström, et al.
Cancer Cell|November 15, 2017
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor ProgressionAsis Palazon, Petros A Tyrakis, David Macias, et al.
The Lancet Regional Health. Europe|September 22, 2025
Prognostic significance of tumour Ki-67 dynamics during neoadjuvant treatment in patients with breast cancer: a population-based cohort studyMaria Angeliki Toli, Xingrong Liu, Davide Massa, et al.
NPJ Breast Cancer|November 20, 2021
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility studyIoannis Zerdes, Michele Simonetti, Alexios Matikas, et al.
Nature Communications|May 7, 2024
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancerKang Wang, Ioannis Zerdes, Henrik J Johansson, et al.
Pageof 13